Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

1. Thompson, A.R. Stucture, function, and molecular defects of factor IX. Blood 67, 565−572 (1986).
2. Prevention and control of haemophilia: Memorandum from a joint WHO/WFA meeting. Bull. World Health Org. 69, 17−26 (1991).
3. Briet, E. Factor IX inhibitors in haemophilia B patients: their incidence and prospects for development with high purity factor IX products. Blood Coag. Fibrin. 2, (suppl 1) 47−50 (1991).
4. Hedner, U. & Davie, E.W. Introduction to hemostasis and the vitamin K dependent coagulation factors in The Metabolic Basis of Inherited Diseases Vol. 2, 6 edn (eds Scriver, C. R. et al.) 2116−2134 (McGraw-Hill, New York, N.Y. 1989).
5. Palmer, T.D., Thompson, A.R. & Miller, A.D. Production of Human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood 73, 438−445 (1989).
6. Scharfmann, R., Axelrod, J.H. & Verma, I.M. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. natn. Acad. Sci. U.S.A. 88, 4626−4630 (1991).
7. Yao, S.N., Wilson, J.M., Nabel, E.G., Kurachi, S., Hachiya, H.L. & Kurachi, K. Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B. Proc. natn. Acad. Sci. U.S.A. 88, 8101−8105 (1991).
8. Gerrard, A.J., Hudson, D.L., Brownlee, G.G. & Watt, F.M. Towards gene therapy for haemophilia B using primary human keratinocytes. Nature Genet. 3, 180−183 (1993).
9. Dai, Y., Roman, M., Naviaux, R.K. & Verma, I.M. Gene therapy in primary myoblasts: long-term expression of factor IX protein following transplantationin vivo. Proc. natn. Acad. Sci. U.S.A. 89, 10892−10895 (1992).
10. Berkner, K.L. Development of adenovirus vectors for the expression of heterologous genes. Bio Techniques 6, 616−629 (1988).
11. Rosenfeld, M.A. et al. Adenovirus-mediated transfer of a recombinant 1-antitrypsin gene to the lung epithelium in vivo.. Science 252, 431−434 (1991).
12. Rosenfeld, M.A. et al. in vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143−155 (1992).
13. Stratford-Perricaudet, L.D., Makeh, I., Perricaudet, M. & Briand, P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. clin. Invest. 90, 626−630 (1992).
14. Mastrangeli, A. et al. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. cin. Invest. 91, 225−234 (1993).
15. Davidson, B.L., Alien, F.D., Kozarsky, K.F., Wilson, J.M. & Roessler, B.J. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3, 219−223 (1993).
16. Akli, S. et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3, 224−228 (1993).
17. Bajocchi, G., Feldman, S.H., Crystal, R.G. & Mastrangeli, A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3, 229−234 (1993).
18. Ragot, T. et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647−650 (1993).
19. Stratford-Perricaudet, L.D., Levrero, M., Chasse, J., Perricaudet, M. & Briand, P. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. gene Ther. 1, 241−256 (1990).
20. Jaffe, H.A. et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372−378 (1992).
21. Li, Q., Kay, M.A., Finegold, M., Stratford-Perricaudet, L.D. & Woo, S.L.C. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. gene Ther. 4, 403−409 (1993).
22. Herz, J. & Gerard, R.D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. natn. Acad. Sci. U.S.A. 90, 2812−2816 (1993).
23. Human gene marker/therapy clinical protocols. Hum. gene Ther. 4, 391−398 (1993).
24. Evans, J.P., Watzke, H.H., Ware, J.L., Stafford, D.W. & High, K.A. Molecular cloning of a cDNA encoding canine factor IX. Blood 74, 207−212 (1989).
25. Thompson, A.R., Palmer, T.D., Lynch, C.M. & Miller, A.D. Gene transfer as an approach to cure patients with hemophilia A or B. in Biotechnology of Plasma Proteins. Curr. Stud. Hematol. Blood Transf. (eds Albertini, A. et al.) 58, 59−62 (Karger, Basel, 1991).
26. Thompson, A.R., Forrey, A.W., Gentry, P.A., Smith, K.J. & Harker, L.A. Human factor IX in animals: kinetics from isolated radiolabeled protein and platelet destruction following crude concentrate infusions. Br. J. Haematol. 45, 329−342 (1980).
27. Smith, K.J. & Thompson, A.R. Labeled factor IX kinetics in patients with hemophilia B. Blood 58, 625−629 (1981).
28. Jallat, S. et al. Characterization of recombinant human factor IX expressed in transgenic mice and in derived transimmortalized hepatic cell lines. EMBO J. 9, 3295−3301 (1990).
29. DiPersio, C.M., Jackson, D.A. & Zaret, K.S. The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Molec. cell. Biol. 11, 4405−4414 (1991).
30. Horwitz, M.S. Adenoviruses in Fields Virology Vol. 2, 2 edn (eds Fields, B.N. & Knipe, D.M.) 1723−1742 (Raven Press, New York, 1990).
31. Strober, S. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. A. Rev. Immunol. 2, 219−237 (1984).
32. Mittal, S.K., McDermott, M.R., Johnson, D.C., Prevec, L. & Graham, F.L. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 28, 67−90 (1993).
33. Shenk, T. & Williams, J. Genetic analysis of adenoviruses. Curr. Top. microbiol. Immunol. 111, 1−39 (1984).
34. Graham, F.L., Smiley, J., Russell, W.C. & Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. gen. Virol. 36, 59−72 (1977).

	Top

	Top